MARS Hero — WP Ready v3
Specialist Clinical Research Company Biostatistics  ·  Evidence Generation  ·  Medical Writing

The Scientific Partner
Trusted by Global Pharma
to Generate Evidence
That Reaches Market.

MARS Global is a premium specialist Clinical Research Company delivering biostatistical rigour, evidence generation, and regulatory-grade medical writing, built for pharma, CROs, and academic institutions across MENA and beyond.

$4M+
Secured in Grants
2,000+
Combined Citations
60+
Peer-Reviewed Publications
21
Countries of Research
6
Scientific Leadership
MARS — Trusted By Band

Trusted by leading organisations across pharma, health systems, and academia

Pharma Clinical Research Health Systems Academic Publishing Government & Funding
Novartis AstraZeneca Abbott Danone Orchidia Pharmaceutical IQVIA GRC Mayo Clinic NMC Royal Abu Dhabi King Faisal Specialist Hospital & Research Centre King Fahad Medical City Saudi CDC ECRRM Abu Dhabi Healthcare Research & Innovation Curtin University Bonn University University of Wurzburg Queen Mary University Fujian Provincial Department of Science & Technology Central Government Special Projects, China Research Square / Springer Nature Bentham Science Publishers
MARS — Services
What We Do

Three Disciplines.
One Scientific Standard.

01

Biostatistics

From study design through to final analysis, MARS Global delivers statistical rigour that withstands regulatory scrutiny. Our biostatisticians are embedded in clinical research from protocol to publication.

Sample Size RCT Analysis Survival Analysis Mixed Models Meta-Analysis R & SAS
Discuss Your Study
02

Medical Writing

Scientific accuracy is not negotiable. MARS Global produces manuscripts, regulatory submissions, and clinical study reports that meet the standards of top-tier journals and global health authorities.

Manuscripts CSRs Systematic Reviews Regulatory Dossiers Q1 Journals
Start a Project
03

Evidence Generation

Market access requires evidence that moves decision-makers. MARS Global designs and delivers real-world evidence strategies, health economics frameworks, and outcomes research built for MENA and global markets.

Real-World Evidence HEOR Outcomes Research E2M Framework Market Access
Explore the E2M Framework
MARS — Published Track Record
Published Track Record

Research That Has Already Reached the World.

Selected examples of published work delivered in partnership with global pharma, health systems, academic institutions, and government bodies. These are examples only — the full body of work spans 60+ peer-reviewed publications across 21 countries.

Selected examples for illustrative purposes only
IQVIA KSA & Abbott KSA
Peer-reviewed publication in collaboration with IQVIA KSA and Abbott KSA, published in the Journal of Clinical Virology
ScienceDirect  ·  Journal of Clinical Virology
View Publication →
IQVIA KSA & Saudi CDC
Publication in collaboration with IQVIA KSA and Saudi Public Health Authority, now the Saudi CDC
MDPI  ·  Tropical Medicine and Infectious Disease
View Publication →
IQVIA UAE & Abbott UAE
Peer-reviewed publication in collaboration with IQVIA UAE and Abbott UAE, published in the Open Respiratory Medicine Journal
Open Respiratory Medicine Journal
View Publication →
Orchidia Pharmaceutical
Published research in partnership with Orchidia Pharmaceutical, featured in Springer
Springer  ·  International Ophthalmology
View Publication →
Danone
Publication in collaboration with Danone, published in JMIR Pediatrics and Parenting
JMIR Pediatrics  ·  2025
View Publication →
Novartis
Peer-reviewed publication supported through collaboration with Novartis, indexed on PubMed
PubMed  ·  NCBI
View Publication →
NMC Royal Abu Dhabi
One of 26 publications produced in collaboration with NMC Royal Abu Dhabi, published in the International Journal of Infectious Diseases
ScienceDirect  ·  IJID
View Publication →
NMC Royal Abu Dhabi
Research in collaboration with NMC Royal Abu Dhabi, published in Frontiers in Medicine
Frontiers in Medicine  ·  2022
View Publication →
NMC Royal Abu Dhabi
Research on Interleukin-6 and determinants of severe disease, in collaboration with NMC Royal Abu Dhabi, published in Medicine (LWW)
LWW Medicine Journal  ·  2023
View Publication →
MARS — Partner Voices
Partner Voices

What Our Partners Say.

"

Consistently impressed with your experience, diligence, efficiency, and ability to get things done in a perfect way.

Yasser Suliman
Engagement Manager, Primary Intelligence
IQVIA KSA
"

Always available once requested — 24/7. A scientific partner who never compromises on quality, regardless of the complexity or urgency of the work.

Dr. Wael Hafez
Internal Medicine Consultant
NMC Royal Hospital Abu Dhabi
"

A rare combination of intellectual versatility, methodological rigour, and an ability to translate complex ideas into actionable insights. Anyone looking for a researcher who is proactive, skilled, and genuinely committed to advancing knowledge would be fortunate to work with this team.

Nasser Al Qhtani
Medical Lead Immunology, Medical Affairs
Healthcare Strategy and Innovation
MARS — Final CTA
Work With Us

Your Research Deserves a Scientific Safeguard.

MARS Global partners with pharma, clinical research companies, and academic institutions that refuse to compromise on scientific standards. Tell us about your project.

60+ Publications 21 Countries $4M+ in Grants 7,144 Researchers Trained
>